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Background: Animal data have suggested that the transient receptor potential ankyrin-1 (TRPA1) ion channel plays a key role in promoting airway inflammation in asthma and may mediate effects of paracetamol on asthma, yet confirmatory human data are lacking. To study associations of TRPA1 gene variants with childhood asthma and total IgE concentration, and interactions between TRPA1 and prenatal paracetamol exposure on these outcomes. 
Methods: We analysed associations between 31 TRPA1 single nucleotide polymorphisms (SNPs) and current doctor-diagnosed asthma and total IgE concentration at 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort. We sought to confirm the most significant associations with comparable outcomes in the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) and Generation R birth cohorts.  In ALSPAC we explored interactions with prenatal paracetamol exposure. 
Results: In ALSPAC there was strong evidence for association between six SNPs and asthma: rs959974 and rs1384001 (per allele odds ratio for both: 1.30 (95% CI: 1.15-1.47), P=0.00001), rs7010969 (OR 1.28 (1.13-1.46), P=0.00004), rs3735945 (OR 1.30 (1.09-1.55), P=0.003), rs920829 (OR 1.30 (1.09-1.54), P=0.004) and rs4738202 (OR 1.22 (1.07-1.39), P=0.004). In a meta-analysis across the three cohorts the pooled effect estimates confirmed that all six SNPs were significantly associated with asthma. In ALSPAC, TRPA1 associations with asthma were not modified by prenatal paracetamol, although associations with IgE concentration were.  
Conclusion: This study suggests that TRPA1 may play a role in the development of childhood asthma. (249 words)
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Introduction
The transient receptor potential ankyrin-1 (TRPA1) ion channel is expressed on peripheral endings of primary afferent neurons and is a highly conserved sensor of noxious reactive electrophiles; these form covalent adducts with the receptor to activate the neurons  ADDIN EN.CITE ().  In particular, TRPA1 is a major oxidant sensor in the airways  ADDIN EN.CITE (), sensing exogenous airborne irritants as well as endogenous by-products of oxidative stress ().  In keeping with this function, the TRPA1 receptor is thought to play a key role in the cough reflex  ADDIN EN.CITE () and in promoting airway inflammation in asthma  ADDIN EN.CITE (, ). Experiments using knock-out mice and TRPA1 antagonists have shown that TRPA1 plays a critical role in allergic and non-allergic neurogenic airway inflammation and hyperreactivity  ADDIN EN.CITE (, ). However, evidence implicating TRPA1 in asthma in humans is lacking.
Following our initial discovery of an association between frequent paracetamol (acetaminophen) use and asthma in adults  ADDIN EN.CITE (), we and others have reported that maternal use of paracetamol in pregnancy was associated with an increased risk of childhood asthma, wheezing and elevated total IgE concentration (). Nassini et al subsequently showed in a rodent model that systemic administration of therapeutic doses of paracetamol led to generation of its electrophilic and reactive metabolite in the lung which, in turn, caused neurogenic airway inflammation through activation of TRPA1; they proposed that this mechanism might explain the epidemiological link between paracetamol exposure and asthma in humans  ADDIN EN.CITE (). 




The Avon Longitudinal Study of Parents and Children (ALSPAC) is a population-based birth cohort that recruited 14,541 predominantly white pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 1992.  Of these pregnancies there were 14,062 live births and 13,988 children alive at one year of age. The cohort has been followed since birth with annual questionnaires and, since age 7 years, with objective measures in research clinics. The study protocol has been described previously  ADDIN EN.CITE (, )  (further information at: http://www.alspac.bris.ac.uk (​http:​/​​/​www.alspac.bris.ac.uk​)). Ethics approval was obtained from the ALSPAC Ethics and Law Committee (IRB 00003312) and the Local Research Ethics Committees.

Outcomes
When the children were 7.5 years old, mothers were asked: ‘Has your child had any of the following in the past 12 months: wheezing; asthma?’.  Children were defined as having current doctor-diagnosed asthma (primary outcome) if mothers responded positively to the question ‘Has a doctor ever actually said that your study child has asthma?’ and positively to one or both of the questions on wheezing and asthma in the past 12 months. 
Serum total IgE concentration (kU/l) was measured by fluoroimmunoassay using the Pharmacia UNICAP system (Pharmacia & Upjohn Diagnostics AB, Uppsala, Sweden) at 7 years.  

Prenatal paracetamol exposure
Mothers were asked at 18 to 20 weeks how often they had taken paracetamol (‘not at all, sometimes, most days, every day’) during their pregnancy. At 32 weeks they were asked the same question about use in the previous 3 months.  Hence we defined use of paracetamol (Yes/No) in early (<18-20 weeks) and late (20-32 weeks) pregnancy. 

Genotyping and selection of TRPA1 SNPs
DNA samples were extracted from lymphoblastoid cell lines, cord blood, or venous blood collected at 7 years of age, with a small number extracted from venous blood collected at 43-61 months.  A total of 9,912 subjects were genotyped at 500,527 SNPs using the Illumina HumanHap550 quad genome-wide SNP genotyping platform.  After applying rigorous exclusion criteria genotype data were available for 8,365 unrelated individuals (see Online Supplement for further details).  
We identified 29 SNPs in TRPA1 (8q13) which had been included in a genetic association study of cough  ADDIN EN.CITE ().  The participating cohorts in that study were part of a large European GWAS of asthma (the GABRIEL consortium)  ADDIN EN.CITE (). All SNPs within the gene region had been selected, allowing capture of the majority of common haplotype variations of the gene  ADDIN EN.CITE (, ). In addition, we identified 11 SNPs (four of which had already been selected) associated with various pain phenotypes  ADDIN EN.CITE () and with menthol preference in smokers  ADDIN EN.CITE (). Of the 36 potential SNPs, five had not been typed or could not be imputed, leaving 31 SNPs to be analysed. Of these SNPs, 21 were genotyped and 10 were imputed.  Where genotyped data were missing these were replaced by imputed data if possible (see Online Table E1 and Supplement for further details). 

Statistical analysis of ALSPAC data
Although the GWAS dataset only included individuals of European ancestry, we excluded mother-child pairs from all analyses if the mother’s reported ethnicity was non-white or unknown (14.1% of the cohort) to further reduce potential confounding by population substructure.  We used logistic regression to analyse relations of child TRPA1 genotype with asthma, and linear regression to analyse associations with log-transformed total IgE concentration.  All analyses were carried out using Stata (version 10.1). Univariate gene main effects were evaluated as continuous per allele effects and using between genotype comparisons. We used Haploview () to compute linkage disequilibrium (LD) statistics for the 31 TRPA1 SNPs of interest. The population-attributable fraction (PAF) was calculated using the formula: PAF=1-PUF, where PUF is the population unattributable fraction ().  We used the Nyholt approach () updated by Li and Ji () to estimate the effective number of independent marker loci in our data (12.8 out of 31) and the threshold required to keep type I error rate at 5% after adjusting for multiple testing (P value=0.05/12.8=0.004). 

PIAMA and Generation R (Netherlands) 
The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort is a multi-centre study that selected 4146 pregnant women in The Netherlands in 1996/97  ADDIN EN.CITE (, ). The Generation R Study is a population-based prospective cohort study of pregnant women and their children in Rotterdam  ADDIN EN.CITE (, ). All children were born between April 2002 and January 2006, and currently followed until young adulthood. Current doctor-diagnosed asthma at 8 years and at 6 years was defined in PIAMA and Generation R, respectively (see Online Supplement for further details).
We analysed the associations between TRPA1 (for SNPs most significantly associated with asthma in ALSPAC) and asthma separately in PIAMA and Generation R, and then undertook a meta-analysis across the three cohorts, using a fixed effects model.

Other European asthma studies 





In ALSPAC, information on current doctor-diagnosed asthma at age 7.5 years was obtained for 7,221 children. After excluding non-white mother-child pairs, and applying quality criteria to imputed genotype data, TRPA1 genotype data were available for 6,901 children, generating a final sample of 5,141 white children with complete data on asthma and genotype, of whom 614 (11.9%) children had current doctor-diagnosed asthma at age 7.5 years. 53.9% and 42.3% of children were exposed to paracetamol in utero during early and late pregnancy, respectively.  Data on total IgE concentration and genotype were available for 3,834 children. 
TRPA1 genotype data are summarised in Table E1.  TRPA1 genotype frequencies did not deviate from Hardy-Weinberg equilibrium for the 31 SNPs of interest (P>0.05). In PIAMA, information on current doctor-diagnosed asthma at age 8 years was obtained for 3,253 children, and TRPA1 genotype data were available for 1,968 children, generating a final sample of 1,877 white children with data on asthma and genotype, of whom 89 (4.7%) had current doctor-diagnosed asthma at age 8 years. In Generation R, data on TRPA1 genotype and current doctor-diagnosed asthma at age 6 years were available for 2,073 children, after excluding twins and restricting to Caucasians only, based on genetic ancestry.  Of these, 64 children (3.1%) had current doctor-diagnosed asthma.

Gene main effects in ALSPAC
Table 1 shows the per allele associations between TRPA1 genotypes and asthma in ALSPAC.  Of the 31 SNPs tested, 13 were associated with asthma (P<0.05). The six SNPs (five genotyped, one imputed) that were most significantly associated with asthma (P<0.005) were: rs959974 and rs1384001 (per allele odds ratio for both SNPs: 1.30 (95% CI: 1.15-1.47), P=0.00001), rs7010969 (OR 1.28 (1.13-1.46), P=0.00004), rs3735945 (OR 1.30 (1.09-1.55), P=0.003), rs920829 (OR 1.30 (1.09-1.54), P=0.004) and rs4738202 (OR 1.22 (1.07-1.39), P=0.004).  Adjustment for multiple testing suggested that associations with these six SNPs (and especially the first four) were unlikely to have arisen by chance (adjusted P value threshold 0.004). With a more rigorous P value threshold of 0.001, evidence against the null hypothesis was still very strong for 3 SNPs.
Additional effect estimates using between genotype comparisons for these six SNPs in relation to asthma are shown in Table 2.  This shows that, for four of these SNPs, children who were homozygous for the risk allele were approximately 70% more likely to have asthma than children who were homozygous for the non-risk allele. Of the 31 SNPs tested, only three (rs959974, rs1384001, rs4738202) were nominally associated with total IgE concentration (P<0.05) (Table E2).  

Figure E1 in the online supplement shows LD (r2) between the 31 TRPA1 SNPs; 29 of those SNPs are located in four LD blocks. Of the six SNPs most significantly associated with asthma, two (rs959974 and rs1384001) were in one block, rs4738202 was in another block, and rs7010969, rs3735945 and rs920829 were in a third block. We chose three of the most significantly associated SNPs from different LD blocks (rs959974, rs7010969 and rs4738202) to separately estimate the proportion of asthma in the population attributable to TRPA1 genotype (PAF). The PAF estimates were, respectively, 21.7% (95% CI: 9.6-32.2; P=0.001), 29.1% (12.5-42.6; P=0.001) and 30.7% (7.7-47.9; P=0.012).

Gene main effects in PIAMA and Generation R and meta-analysis 
Table 2 also shows the associations between the six SNPs most significantly associated with asthma in ALSPAC and asthma in the PIAMA and Generation R cohorts.  In PIAMA there was some evidence for association (P≤0.05) with asthma for the three SNPs most significantly associated in ALSPAC, with effect estimates that were larger than those in ALSPAC. In Generation R none of the six SNPs were associated with asthma. Figure 1 shows the Forest plots for the weighted per-allele associations of the six SNPs with asthma. For all six SNPs the pooled effect estimates confirmed significant associations with asthma.   

Gene main effects in other European asthma studies
Figures E2-E6 online show Forest plots for the meta-analysis of the associations between TRPA1 and childhood-onset asthma across GABRIEL studies, for five of the six SNPs most significantly associated with asthma in ALSPAC (rs920829 was not genotyped in GABRIEL; it was imputed in ALSPAC, but is in strong LD with rs3735945).  The plots compare associations with current doctor-diagnosed asthma in ALSPAC and PIAMA versus associations with doctor-diagnosed asthma ‘ever’ (of childhood-onset) across other GABRIEL studies, with three studies which were exclusively of children separated from remaining studies. The pooled effect estimates do not confirm associations with asthma ‘ever’. Furthermore, there was evidence of substantial heterogeneity in the effect estimates for the three childhood GABRIEL studies. 

Paracetamol analyses in ALSPAC




We found strong evidence for an association between TRPA1 polymorphisms and asthma in children at 7-8 years of age in the population-based ALSPAC birth cohort. Of the six SNPs most significantly associated with asthma in ALSPAC, three showed some evidence of association (and larger effect estimates) with a similar asthma phenotype in the PIAMA birth cohort, whilst none of the six SNPs were associated with asthma at 6 years in Generation R. However, both PIAMA and Generation R were considerably smaller, and had a lower prevalence of current asthma, than ALSPAC, and hence lacked statistical power to replicate findings individually. When we meta-analysed across all three birth cohorts the pooled effect estimates confirmed associations with asthma overall. Given the a priori selection of SNPs, the level of statistical significance for the ‘top hits’ in the ALSPAC discovery dataset, and supportive evidence in PIAMA and following meta-analysis across all three cohorts, we believe these results may represent a causal influence of the TRPA1 gene on the risk of active childhood asthma. Other genes in the vicinity of TRPA1 are unlikely to explain our findings as there is little apparent LD extending between TRPA1 and other nearby genes (1000 Genomes Phase 1 CEU (www.1000genomes.org)). To our knowledge these findings are novel, and suggest that TRPA1 may play a role in the development of childhood asthma. Whilst a recent study reported correlations between two TRPA1 polymorphisms and asthma control in children with asthma  ADDIN EN.CITE (), it was underpowered and statistical evidence was weak.       

Importance of asthma phenotype
There is likely to be genetic heterogeneity of asthma phenotypes in childhood  ADDIN EN.CITE (), as demonstrated for adult asthma phenotypes  ADDIN EN.CITE (). This may partly explain why TRPA1 was not associated with asthma in the other European studies. A limitation of the GABRIEL asthma GWAS was that the asthma ‘ever’ phenotype was not directly comparable to the ‘current’ asthma phenotype used in ALSPAC, PIAMA and Generation R; a doctor diagnosis of asthma ‘ever’ is likely to comprise many different phenotypes or endotypes which, when analysed together, may lead to dilution of effects of genetic variants  ADDIN EN.CITE (). For example, in children, ‘asthma ever’ may capture early transient childhood wheezing. We confirmed that the effect estimates for the association between TRPA1 and asthma were smaller in ALSPAC, and especially in PIAMA, when we analysed ‘ever’ asthma rather than ‘current’ asthma in these cohorts. Other possible reasons for the lack of association across the other European studies include differences in how cases were selected, which may have contributed to heterogeneity of the asthma phenotype; unreliability of recall of childhood onset asthma amongst the adult studies in GABRIEL; and variation in the prevalence of environmental exposures that interact with the gene across different European populations  ADDIN EN.CITE (). 

Mechanisms
Given that reactive oxygen species are thought to play an important role in the pathogenesis of airways disease (), and the TRPA1 receptor is an important oxidant sensor expressed on sensory neurons innervating the airways  ADDIN EN.CITE (), it seems plausible that TRPA1 may play a critical role in asthma pathogenesis. Activation of TRPA1 can, through release of neuropeptides, promote neurogenic airway inflammation  ADDIN EN.CITE (, ). Conversely, in murine models of airway inflammation induced by allergen, cigarette smoke and paracetamol, deletion or antagonism of TRPA1 has been shown to reduce airway inflammation and hyper-reactivity  ADDIN EN.CITE (, , ).  However, as neurogenic inflammation has not been demonstrated in human asthma, there are two other mechanisms to consider.  First, TRPA1 may also influence airway inflammation non-neuronally, as confirmed in animals  ADDIN EN.CITE (), and recent in vitro studies have shown that TRPA1 is functionally expressed in human lung, including pulmonary epithelial cells  ADDIN EN.CITE (, ), smooth muscle cells  ADDIN EN.CITE (), and lung fibroblasts  ADDIN EN.CITE (). Second, a neuronal reflex mechanism may be involved, as suggested by experiments in rodents  ADDIN EN.CITE ().  

The lack of modification of the association between TRPA1 and asthma by prenatal paracetamol exposure suggests that, even if fetal TRPA1 is activated by exposure to the metabolite of paracetamol  ADDIN EN.CITE () in utero, this mechanism is unlikely to explain the association between prenatal paracetamol and asthma.  The apparent interaction we observed between prenatal paracetamol exposure and TRPA1 genotype on IgE concentration is intriguing, but may be a chance finding and we cannot offer a mechanistic explanation. We speculate that other prenatal and postnatal oxidant exposures may be more important than paracetamol as activators of TRPA1, thus contributing to the association we have found between TRPA1 genotype and childhood asthma. 

Conclusions and future work 
Our findings suggest, for the first time, that TRPA1 may play a role in the development of childhood asthma. In terms of therapeutic implications, these data lend further support to the proposition that TRPA1 antagonists may have promising potential in asthma  ADDIN EN.CITE ().  It is important that our findings are further replicated in adequately powered studies with comparable asthma phenotypes, and we plan to explore interactions between TRPA1 and other oxidant exposures such as tobacco smoke and air pollution on childhood respiratory outcomes. 
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Table 1: Per-allele associations between child TRPA1 SNPs and current doctor diagnosed asthma at 7.5 years in ALSPAC 

SNP	Position 	Doctor diagnosed asthma at 7 years





rs959974	72935839	5141	1.30 (1.15-1.47)	    0.00001
rs959976	72936145	5141	1.22 (1.05-1.42)	0.008





































	G/T	2,615	1.33 (1.07-1.65)	0.009	932	1.36 (0.77-2.38)	0.28	1,054	1.15 (0.61, 2.14)	0.67
	T/T	1,125	1.69 (1.32-2.16)	0.00001	433	1.82 (0.99-3.36)	0.053	464	1.39 (0.68, 2.82)	0.37
	Per allele		1.30 (1.15-1.47)	0.00001		1.35 (1.00-1.83)	0.052		1.18 (0.83, 1.68)	0.37
										
rs1384001†	C/C	1400	1.00		512	1.00		555	1.00	
	A/C	2,616	1.33 (1.07-1.65)	0.009	933	1.36 (0.78-2.38)	0.28	1,054	1.15 (0.61, 2.14)	0.67
	A/A	1125	1.69 (1.32-2.15)	0.00001	432	1.83 (0.99-3.37)	0.053	464	1.39 (0.68, 2.82)	0.37
	Per allele		1.30 (1.15-1.47)	0.00001		1.35 (1.00-1.83)	0.051		1.18 (0.83, 1.68)	0.37
										
rs4738202*	A/A	483	1.00		150	1.00		179	1.00	
	A/G	2,233	1.45 (1.02-2.05)	0.038	816	1.54 (0.54-4.41)	0.42	880	0.71 (0.30, 1.68)	0.44
	G/G	2,425	1.66 (1.18-2.34)	0.004	911	2.21 (0.79-6.20)	0.13	1,014	0.78 (0.34, 1.81)	0.57
	Per allele		1.22 (1.07-1.39)	0.004		1.45 (1.01-2.09)	0.042		0.96 (0.65, 1.41)	0.83
										
rs7010969†	A/A	827	1.00		299	1.00		324	1.00	
	A/C	2,477	1.43 (1.09-1.89)	0.010	920	1.09 (0.56-2.10)	0.80	1,005	1.08 (0.51, 2.32)	0.84
	C/C	1,837	1.74 (1.31-2.29)	0.00005	658	1.42 (0.73-2.77)	0.30	744	1.20 (0.55, 2.62)	0.65
	Per allele		1.28 (1.13-1.46	0.00004		1.23 (0.89-1.68)	0.21		1.10 (0.76, 1.59)	0.61
										
rs3735945†	C/C	4,067	1.00		1519	1.00		1,621	1.00	
	C/T	1,005	1.38 (1.13-1.68)	0.002	338	1.15 (0.67-1.95)	0.61	428	1.40 (0.80, 2.47)	0.24
	T/T	69	1.19 (0.59-2.41)	0.633	20	0.00 (0.00- -)¶	0.99	24	0.00 (0.00- -)¶	0.99
	Per allele		1.30 (1.09-1.55)	0.003		1.01 (0.61-1.65)	0.98		1.21 (0.71, 2.04)	0.48
										
rs920829#	C/C	4,066	1.00		1519	1.00		1,621	1.00	
	C/T	1001	1.37 (1.12-1.68)	0.002	338	1.15 (0.67-1.95)	0.61	428	1.40 (0.80, 2.47)	0.24
	T/T	69	1.19 (059-2.41)	0.634	20	0.00 (0.00- -)¶	0.99	24	0.00 (0.00- -)¶	0.99
	Per allele 		1.30 (1.09-1.54)	0.004		1.01 (0.61-1.65)	0.98		1.21 (0.71, 2.04)	0.48




Table 3: Per-allele associations between the six most significantly associated TRPA1 SNPs and current doctor diagnosed asthma, stratified by prenatal paracetamol exposure during early and late gestation in ALSPAC


SNP	N	Paracetamol early in pregnancy OR (95% C.I.)	p-value	N	Paracetamol later in pregnancy OR (95% C.I.)	p-value
rs959974						
	Exposed 	2,734	1.29 (1.10-1.50)	0.002	2,118	1.26 (1.06-1.50)	0.008
	Unexposed 	2,338	1.37 (1.12-1.66)	0.002	2,889	1.31 (1.10-1.56)	0.002
		p-interaction	0.639		p-interaction	0.765
rs1384001						
	Exposed 	2,734	1.29 (1.10-1.50)	0.002	2,118	1.26 (1.06-1.50)	0.008
	Unexposed 	2,338	1.37 (1.12-1.66)	0.002	2,889	1.31 (1.10-1.56)	0.002
		p-interaction	0.643		p-interaction	0.760
rs4738202						
	Exposed 	2,734	1.22 (1.03-1.45)	0.024	2,118	1.23 (1.02-1.49)	0.031
	Unexposed 	2,338	1.24 (1.00-1.54)	0.049	2,889	1.18 (0.97-1.43)	0.090
		p-interaction	0.910		p-interaction	0.753
rs7010969						
	Exposed 	2,734	1.25 (1.07-1.47)	0.006	2,118	1.25 (1.05-1.50)	0.012
	Unexposed 	2,338	1.34 (1.09-1.64)	0.005	2,889	1.31 (1.09-1.57)	0.003
		p-interaction	  0.621		p-interaction	0.738
rs3735945						
        Exposed 	2,734	1.15 (0.91-1.44)	0.242	2,118	1.31 (1.02-1.68)	0.036
       Unexposed 	2,338	1.59 (1.20-2.09)	0.001	2,889	1.24 (0.96-1.60)	0.096
		p-interaction	0.076		p-interaction 	0.755
rs920829						
       Exposed 	2,732	1.15 (0.91-1.44)	0.238	2,114	1.30 (1.01-1.67)	0.041













Table 4: Per-allele associations between the three most significantly associated TRPA1 SNPs and total IgE concentration, stratified by prenatal paracetamol exposure during early and late gestation in ALSPAC

SNP	N	Paracetamol early in pregnancy GMR* (95% C.I.)	p-value	N	Paracetamol later in pregnancy GMR* (95% C.I.)	p-value
rs959974						
	Exposed 	2066	1.12 (1.01-1.24)	0.037	1587	1.22 (1.08-1.37)	0.001
	Unexposed 	1719	1.05 (0.94-1.17)	0.408	2149	1.01 (0.91-1.12)	0.849
		p-interaction	0.414		p-interaction	0.017
rs1384001						
	Exposed 	2066	1.12 (1.01-1.24)	0.037	1587	1.22 (1.08-1.37)	0.001
	Unexposed 	1719	1.05 (0.94-1.17)	0.402	2149	1.01 (0.91-1.12)	0.849
		p-interaction	0.418		p-interaction	0.016
rs4738202						
	Exposed 	2066	1.16 (1.03-1.29)	0.011	1587	1.21 (1.06-1.37)	0.003
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